Impact of Macrolides on Critically Ill Patients with Community-acquired Pneumonia

大环内酯类药物对社区获得性肺炎危重患者的影响

• 批准号: 486097
• 负责人: Qaddoura Amro
• 金额: $ 1.27万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-12-01 至 2023-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486097&lang=en
• 关键词: Critical Illness; Macrolide; Pneumonia

Pneumonia is a common lung infection that can cause severe illness and inflammation. Pneumonia is treated with antibiotics, and one of the antibiotic groups used to treat it are called “macrolides.” Macrolides have infection-fighting properties, but can a

肺炎是一种常见的肺部感染，可导致严重的疾病和炎症。肺炎是用抗生素治疗的，用于治疗它的抗生素组之一被称为“大环内酯类”。大环内酯类药物具有抗感染的特性，但